Perception of couples' on multipurpose prevention technology attribute choice: the case of MTN 045.

Autor: Dandadzi A; University of Zimbabwe-Clinical Trials Research Centre, Harare, Zimbabwe. adandadzi@uz-ctrc.org., Young AM; Women's Global Health Imperative, RTI International, Berkeley, CA, USA.; Department of Maternal and Child Health, University of North Carolina, Chapel Hill, NC, USA., Musara P; University of Zimbabwe-Clinical Trials Research Centre, Harare, Zimbabwe., Shapley-Quinn MK; Women's Global Health Imperative, RTI International, Berkeley, CA, USA., Kemigisha D; Makerere University-Johns Hopkins Research Collaboration, Kampala, Uganda., Mutero P; University of Zimbabwe-Clinical Trials Research Centre, Harare, Zimbabwe., Mgodi NM; University of Zimbabwe-Clinical Trials Research Centre, Harare, Zimbabwe., Etima J; Makerere University-Johns Hopkins Research Collaboration, Kampala, Uganda., Minnis AA; Women's Global Health Imperative, RTI International, Berkeley, CA, USA.
Jazyk: angličtina
Zdroj: BMC public health [BMC Public Health] 2024 Jul 15; Vol. 24 (1), pp. 1876. Date of Electronic Publication: 2024 Jul 15.
DOI: 10.1186/s12889-024-19390-0
Abstrakt: Background: Multipurpose prevention technologies (MPTs) are products capable of simultaneously addressing multiple sexual and reproductive health needs such as unwanted pregnancy, STIs including HIV-1, and other reproductive tract infections. MPTs are urgently needed to address the double burden of unplanned pregnancy and HIV. While condoms are currently the only accessible MPTs, they are not solely under a woman's control, and female condoms face limitations due to poor acceptability and high cost.
Methods: We conducted a sub-analysis of qualitative data from 39 couples participating in the MTN 045 study to examine the perception of couples on choice and acceptability of a "2 in 1" MPT that combines HIV and pregnancy prevention.
Results: Couples recognized the benefits of MPTs for HIV and pregnancy prevention but perceptions tied to each indication and a novel prevention technology tool raised important concerns relevant to use of future MPTs. In the study, participants' perceptions of MPT use were influenced by pregnancy planning. When the timing was less critical, they prioritized HIV prevention. Misinformation about family planning methods, including MPTs, affected decision-making with potential to hinder uptake of future MPTs. Concerns about side effects, such as weight gain and hormonal imbalances, influenced willingness to use MPTs.
Conclusion: Addressing the myths and misconceptions surrounding the use of contraceptives is crucial in promoting their acceptance and ultimate use. Strategies for addressing the drawbacks women might experience while using a particular product should be in place as new MPTs progress through the development pipeline and approach roll-out.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje